Carregant...
Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy
Tumor treatment is still complicated in the field of medicine. Tumor immunotherapy has been the most interesting research field in cancer therapy. Application of chimeric antigen receptor T (CAR-T) cell therapy has recently achieved excellent clinical outcome in patients, especially those with CD19-...
Guardat en:
| Publicat a: | Mol Cancer |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5956614/ https://ncbi.nlm.nih.gov/pubmed/29769134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-018-0840-y |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|